Home › Companies › VIKING THERAPEUTICS INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and VIKING THERAPEUTICS INC.’s Form 8-K, filed May 23, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of May 21, 2024: 6 items on VIKING THERAPEUTICS INC.’s Form 8-K, filed May 23, 2024: 4 approved · 1 passed (calculated) · 1 plurality election.
Significant dissent: 2 directors (67.2%, 25.7% against).
Notable dissent: 1 other board item (28.4% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore VIKING THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are VIKING THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 23, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Brian Lian, Ph.D. | 50,502,615 | -- | -- | 17,436,415 | 20,260,462 | 74% | Passed (calculated) | — |
| Elect Director: Lawson Macartney, Ph.D. | 22,267,255 | -- | -- | 45,671,775 | 20,260,462 | 33% | Plurality election | — |
| 2. To ratify the selection of Marcum LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2024 | 87,382,144 | 743,579 | 73,767 | -- | -- | 99.2% | Approved | — |
| 3. To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement | 63,234,707 | 4,510,461 | 193,862 | -- | 20,260,462 | 93% | Approved | — |
| 4. To approve the 2024 EIP | 48,547,615 | 19,279,010 | 112,405 | -- | 20,260,462 | 72% | Approved | — |
| 5. To approve the 2024 ESPP | 67,119,655 | 734,042 | 85,333 | -- | 20,260,462 | 99% | Approved | — |
Source: VIKING THERAPEUTICS INC., Form 8-K, filed with the SEC on May 23, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
372 asset managers disclosed a vote on at least one VIKING THERAPEUTICS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of VIKING THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 9 wordings of this item as funds reported it.
74% Majority: yes · of votes cast
Description as filed by funds: ELECTION OF DIRECTORS FOR CLASS III (term to expire in 2027): Brian Lian, Ph.D.
VIKING THERAPEUTICS INC.’s own tally for this item (“Elect Director: Brian Lian, Ph.D.”): 50,502,615 for, 17,436,415 withheld, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 74% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 108 asset managers below reported 25,130,078 for, 10,498,885 withheld, 147,035 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 1,799,363 | 0 | 0 | 10,364,868 | Mixed |
| Vanguard | 7,702,135 | 0 | 0 | 0 | For |
| BlackRock | 3,600,224 | 0 | 0 | 0 | For |
| State Street | 1,047,464 | 0 | 0 | 112 | For |
| Charles Schwab | 838,984 | 0 | 0 | 0 | For |
| American Century | 769,898 | 0 | 0 | 0 | For |
| Voya | 611,073 | 0 | 0 | 0 | For |
| JPMorgan | 577,597 | 0 | 0 | 0 | For |
| AllianceBernstein | 568,931 | 0 | 0 | 0 | For |
| TIAA | 411,560 | 0 | 0 | 0 | For |
| Invesco | 351,183 | 0 | 0 | 0 | For |
| Legg Mason | 345,200 | 0 | 0 | 0 | For |
| Equitable | 336,330 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 336,235 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 316,600 | 0 | 0 | 0 | For |
| Principal | 232,360 | 0 | 0 | 82,717 | Mixed |
| Putnam | 311,905 | 0 | 0 | 0 | For |
| Lord Abbett | 277,398 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 269,469 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 267,893 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 266,975 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 262,710 | 0 | 0 | 0 | For |
| MFS | 251,577 | 0 | 0 | 0 | For |
| Victory Capital | 243,208 | 0 | 0 | 0 | For |
| Jackson National | 236,307 | 0 | 1,934 | 0 | For |
Showing the 25 largest of 108 asset managers. All 108 are in the interactive database (link above).
Combines 9 wordings of this item as funds reported it.
33% Plurality election · of votes cast
Description as filed by funds: ELECTION OF DIRECTORS FOR CLASS III (term to expire in 2027): Lawson Macartney, DVM, Ph.D.
VIKING THERAPEUTICS INC.’s own tally for this item (“Elect Director: Lawson Macartney, Ph.D.”): 22,267,255 for, 45,671,775 withheld, per its Form 8-K filed May 23, 2024 (Item 5.07). This is a for/withhold election, which is decided by plurality: a nominee does not need a majority of the votes cast to be elected, so no passed or failed outcome is stated here.
Outcome: Plurality election — The company’s filing reports the vote counts but does not state the outcome; this is an election decided by plurality, so a nominee does not need a majority of the votes cast and no passed or failed outcome is calculated.
Support: 33% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 108 asset managers below reported 11,425,236 for, 30 against, 23,595,083 withheld, 755,649 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 1,697,041 | 0 | 0 | 10,467,190 | Mixed |
| Vanguard | 7,513,035 | 0 | 0 | 189,100 | For |
| BlackRock | 0 | 0 | 0 | 3,600,224 | Withhold |
| State Street | 1,032 | 0 | 0 | 1,046,544 | Withhold |
| Charles Schwab | 0 | 0 | 0 | 838,984 | Withhold |
| American Century | 0 | 0 | 0 | 769,898 | Withhold |
| Voya | 0 | 0 | 0 | 611,073 | Withhold |
| JPMorgan | 577,597 | 0 | 0 | 0 | For |
| AllianceBernstein | 0 | 0 | 0 | 568,931 | Withhold |
| TIAA | 0 | 0 | 0 | 411,560 | Withhold |
| Invesco | 0 | 0 | 0 | 351,183 | Withhold |
| Legg Mason | 0 | 0 | 0 | 345,200 | Withhold |
| Equitable | 0 | 0 | 0 | 336,330 | Withhold |
| Delaware/Macquarie | 0 | 0 | 0 | 336,235 | Withhold |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 0 | 0 | 0 | 316,600 | Withhold |
| Principal | 163 | 0 | 0 | 314,914 | Withhold |
| Putnam | 311,905 | 0 | 0 | 0 | For |
| Lord Abbett | 277,398 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 269,469 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 0 | 0 | 0 | 267,893 | Withhold |
| Columbia Threadneedle | 0 | 0 | 0 | 266,975 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 262,710 | Withhold |
| MFS | 0 | 0 | 0 | 251,577 | Withhold |
| Victory Capital | 0 | 0 | 0 | 243,208 | Withhold |
| Jackson National | 0 | 0 | 238,241 | 0 | Abstain |
Showing the 25 largest of 108 asset managers. All 108 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.1% of fund votes cast · no official result
Description as filed by funds: TO APPROVE OUR 2024 EMPLOYEE STOCK PURCHASE PLAN.
The 111 asset managers below reported 35,457,083 for, 312,110 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 12,164,231 | 0 | 0 | 0 | For |
| Vanguard | 7,702,135 | 0 | 0 | 0 | For |
| BlackRock | 3,600,224 | 0 | 0 | 0 | For |
| State Street | 1,047,576 | 0 | 0 | 0 | For |
| Charles Schwab | 838,984 | 0 | 0 | 0 | For |
| American Century | 769,898 | 0 | 0 | 0 | For |
| Voya | 611,073 | 0 | 0 | 0 | For |
| JPMorgan | 577,597 | 0 | 0 | 0 | For |
| AllianceBernstein | 568,931 | 0 | 0 | 0 | For |
| TIAA | 411,560 | 0 | 0 | 0 | For |
| Invesco | 351,183 | 0 | 0 | 0 | For |
| Legg Mason | 345,200 | 0 | 0 | 0 | For |
| Equitable | 336,330 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 336,235 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 316,600 | 0 | 0 | 0 | For |
| Principal | 315,077 | 0 | 0 | 0 | For |
| Putnam | 311,905 | 0 | 0 | 0 | For |
| Lord Abbett | 277,398 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 269,469 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 267,893 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 266,975 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 262,710 | 0 | 0 | 0 | For |
| MFS | 0 | 251,577 | 0 | 0 | Against |
| Victory Capital | 243,208 | 0 | 0 | 0 | For |
| Jackson National | 238,241 | 0 | 0 | 0 | For |
Showing the 25 largest of 111 asset managers. All 111 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
79% of fund votes cast · no official result
Description as filed by funds: TO APPROVE OUR 2024 EQUITY INCENTIVE PLAN.
The 111 asset managers below reported 28,155,855 for, 7,606,377 against, 6,961 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 12,124,513 | 39,718 | 0 | 0 | For |
| Vanguard | 7,702,135 | 0 | 0 | 0 | For |
| BlackRock | 3,600,224 | 0 | 0 | 0 | For |
| State Street | 1,032 | 1,046,544 | 0 | 0 | Against |
| Charles Schwab | 838,984 | 0 | 0 | 0 | For |
| American Century | 0 | 769,898 | 0 | 0 | Against |
| Voya | 0 | 611,073 | 0 | 0 | Against |
| JPMorgan | 577,597 | 0 | 0 | 0 | For |
| AllianceBernstein | 568,931 | 0 | 0 | 0 | For |
| TIAA | 0 | 411,560 | 0 | 0 | Against |
| Invesco | 351,183 | 0 | 0 | 0 | For |
| Legg Mason | 345,200 | 0 | 0 | 0 | For |
| Equitable | 336,330 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 336,235 | 0 | 0 | Against |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 0 | 316,600 | 0 | 0 | Against |
| Principal | 201,278 | 113,799 | 0 | 0 | Mixed |
| Putnam | 0 | 311,905 | 0 | 0 | Against |
| Lord Abbett | 0 | 277,398 | 0 | 0 | Against |
| MUTUAL FUND SERIES TRUST | 16,500 | 252,969 | 0 | 0 | Mixed |
| AB DISCOVERY GROWTH FUND, INC. | 267,893 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 266,975 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 262,710 | 0 | 0 | Against |
| MFS | 0 | 251,577 | 0 | 0 | Against |
| Victory Capital | 0 | 243,208 | 0 | 0 | Against |
| Jackson National | 140,222 | 98,019 | 0 | 0 | Mixed |
Showing the 25 largest of 111 asset managers. All 111 are in the interactive database (link above).
Combines 16 wordings of this item as funds reported it.
93% Approved · of votes cast
Prior year: 97.6% for (June 13, 2023 meeting) ▼ 4.3 pts
Description as filed by funds: To approve, on an advisory basis, the compensation of our named executive officers.
VIKING THERAPEUTICS INC.’s own tally for this item (“3. To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement”): 63,234,707 for, 4,510,461 against — passed, per its Form 8-K filed May 23, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “As a result, the Company's stockholders voted to approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement.”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 12,164,231 | 0 | 0 | 0 | For |
| Vanguard | 7,702,135 | 0 | 0 | 0 | For |
| BlackRock | 3,600,224 | 0 | 0 | 0 | For |
| State Street | 1,047,331 | 245 | 0 | 0 | For |
| Charles Schwab | 838,984 | 0 | 0 | 0 | For |
| American Century | 0 | 769,898 | 0 | 0 | Against |
| Voya | 611,073 | 0 | 0 | 0 | For |
| JPMorgan | 577,597 | 0 | 0 | 0 | For |
| AllianceBernstein | 568,931 | 0 | 0 | 0 | For |
| TIAA | 411,560 | 0 | 0 | 0 | For |
| Invesco | 351,183 | 0 | 0 | 0 | For |
| Legg Mason | 345,200 | 0 | 0 | 0 | For |
| Equitable | 336,330 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 336,235 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 0 | 316,600 | 0 | 0 | Against |
| Principal | 315,077 | 0 | 0 | 0 | For |
| Putnam | 311,905 | 0 | 0 | 0 | For |
| Lord Abbett | 277,398 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 269,469 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 267,893 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 266,975 | 0 | 0 | Against |
| AIG/SunAmerica | 262,710 | 0 | 0 | 0 | For |
| MFS | 251,577 | 0 | 0 | 0 | For |
| Victory Capital | 243,208 | 0 | 0 | 0 | For |
| Jackson National | 238,241 | 0 | 0 | 0 | For |
Fund voting reports, all 106 managers: 33,697,793 for, 1,972,972 against, 18,525 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 16,346,837 | 0 | 0 | 0 | For |
| State Street | 3,005,218 | 326 | 0 | 0 | For |
| BlackRock | 2,750,147 | 14,865 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,841,944 | 0 | 0 | 0 | For |
| AllianceBernstein | 1,439,494 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 1,234,936 | 0 | 0 | 0 | For |
| VIKING GLOBAL INVESTORS LP | 1,094,940 | 0 | 0 | 0 | For |
| Charles Schwab | 855,375 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 818,055 | 0 | 0 | 0 | For |
| American Century | 0 | 759,217 | 0 | 0 | Against |
| JPMorgan | 754,651 | 0 | 0 | 0 | For |
| Voya | 740,991 | 0 | 0 | 0 | For |
| Avoro Capital Advisors LLC | 673,864 | 0 | 0 | 0 | For |
| Clearbridge Investments, LLC | 596,976 | 0 | 0 | 0 | For |
| Northern Trust | 569,391 | 73 | 0 | 0 | For |
| Citadel | 563,735 | 0 | 0 | 0 | For |
| BAMCO INC /NY/ | 0 | 480,173 | 0 | 0 | Against |
| BRAIDWELL LP | 470,839 | 0 | 0 | 0 | For |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 463,501 | 0 | 0 | 0 | For |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 441,228 | 21,987 | 0 | 0 | For |
| Nuveen | 454,773 | 0 | 0 | 0 | For |
| MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 446,776 | 0 | 0 | 0 | For |
| Artia Global Partners LP | 432,129 | 0 | 0 | 0 | For |
| FRED ALGER MANAGEMENT, LLC | 11,414 | 416,227 | 0 | 0 | Against |
| Invesco | 420,879 | 0 | 0 | 0 | For |
Institutional-manager reports, all 293 managers: 45,029,858 for, 3,078,995 against, 150 withheld, 56 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.2% Approved · of votes cast
Prior year: 99.8% for (June 13, 2023 meeting) ▼ 0.6 pts
Description as filed by funds: RATIFICATION OF THE SELECTION OF MARCUM LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2024.
VIKING THERAPEUTICS INC.’s own tally for this item (“2. To ratify the selection of Marcum LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2024”): 87,382,144 for, 743,579 against — passed, per its Form 8-K filed May 23, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “As a result, the Company's stockholders voted to ratify the selection of Marcum LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2024.”
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of VIKING THERAPEUTICS INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Ratify Appointment of Independent Auditors” (2 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).
The 109 asset managers below reported 35,779,182 for, 164 against, 18,525 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 12,164,231 | 0 | 0 | 0 | For |
| Vanguard | 7,702,135 | 0 | 0 | 0 | For |
| BlackRock | 3,600,224 | 0 | 0 | 0 | For |
| State Street | 1,047,412 | 164 | 0 | 0 | For |
| Charles Schwab | 838,984 | 0 | 0 | 0 | For |
| American Century | 769,898 | 0 | 0 | 0 | For |
| Voya | 611,073 | 0 | 0 | 0 | For |
| JPMorgan | 577,597 | 0 | 0 | 0 | For |
| AllianceBernstein | 568,931 | 0 | 0 | 0 | For |
| TIAA | 411,560 | 0 | 0 | 0 | For |
| Invesco | 351,183 | 0 | 0 | 0 | For |
| Legg Mason | 345,200 | 0 | 0 | 0 | For |
| Equitable | 336,330 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 336,235 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 316,600 | 0 | 0 | 0 | For |
| Principal | 315,077 | 0 | 0 | 0 | For |
| Putnam | 311,905 | 0 | 0 | 0 | For |
| Lord Abbett | 277,398 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 269,469 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 267,893 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 266,975 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 262,710 | 0 | 0 | 0 | For |
| MFS | 251,577 | 0 | 0 | 0 | For |
| Victory Capital | 243,208 | 0 | 0 | 0 | For |
| Jackson National | 238,241 | 0 | 0 | 0 | For |
Showing the 25 largest of 109 asset managers. All 109 are in the interactive database (link above).
Not shown here: this season’s fund filings also report 1 item from the meeting of May 20, 2025, which belongs to the 2024-2025 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 110,228,869 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 11.04% |
| 2 | Vanguard | 6.99% |
| 3 | BlackRock | 3.27% |
| 4 | State Street | 0.95% |
| 5 | Charles Schwab | 0.76% |
| 6 | American Century | 0.70% |
| 7 | Voya | 0.55% |
| 8 | JPMorgan | 0.52% |
| 9 | AllianceBernstein | 0.52% |
| 10 | TIAA | 0.37% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 14.83% |
| 2 | State Street | 2.73% |
| 3 | BlackRock | 2.51% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 1.67% |
| 5 | AllianceBernstein | 1.31% |
| 6 | PICTET ASSET MANAGEMENT SA | 1.12% |
| 7 | VIKING GLOBAL INVESTORS LP | 0.99% |
| 8 | Charles Schwab | 0.78% |
| 9 | PNC BANK, NATIONAL ASSOCIATION | 0.74% |
| 10 | American Century | 0.69% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| FMR LLC | 15,004,340 | 13.61% | Proxy statement (DEF 14A), proxy filed April 5, 2024 |
| Vanguard Group | 9,999,107 | 9.07% | Form 13F, quarter ended March 31, 2024 |
| FMR (Fidelity) | 5,790,051 | 5.25% | Form 13F, quarter ended March 31, 2024 |
| BlackRock | 5,596,166 | 5.08% | Form 13F, quarter ended March 31, 2024 |
| Entities Associated with Viking Global Investors LP | 5,145,112 | 4.67% | Proxy statement (DEF 14A), proxy filed April 5, 2024 |
| Morgan Stanley | 3,729,117 | 3.38% | Form 13F, quarter ended March 31, 2024 |
| Brian Lian, Ph.D. | 3,401,038 | 3.09% | Proxy statement (DEF 14A), proxy filed April 5, 2024 |
| State Street | 3,326,567 | 3.02% | Form 13F, quarter ended March 31, 2024 |
| Citadel Advisors | 3,118,649 | 2.83% | Form 13F, quarter ended March 31, 2024 |
| JPMorgan Chase | 2,577,087 | 2.34% | Form 13F, quarter ended March 31, 2024 |
Percentages above are of 110,228,869 shares outstanding, as reported by VIKING THERAPEUTICS INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At VIKING THERAPEUTICS INC.'s shareholder meeting held May 21, 2024, in the 2023-2024 proxy season, 372 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 2,500 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of our named executive officers. — VIKING THERAPEUTICS INC.'s filing reports the proposal as approved, with 93% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: VIKING THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 23, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from VIKING THERAPEUTICS INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
VIKING THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Proxy Votes Now, “VIKING THERAPEUTICS (VKTX) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/viking-therapeutics-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.